TIDMLMT

RNS Number : 7725A

Lombard Medical Technologies PLC

25 March 2013

 
 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
---------------------------------------------------------------------------------------------------------------------------------- 
 
 1. Identity of the issuer or the underlying                                                      LOMBARD MEDICAL TECHNOLOGIES PLC 
  issuer 
  of existing shares to which voting rights 
  are 
  attached: (ii) 
------------------------------------------------------------------------------  -------------------------------------------------- 
 2 Reason for the notification (please tick the appropriate box or boxes): 
---------------------------------------------------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights                                                                                  X 
-------------------------------------------------------------------------------------------------------------------------  ------- 
 An acquisition or disposal of qualifying financial instruments 
  which may result in the acquisition of shares already issued to 
  which voting rights are attached 
-------------------------------------------------------------------------------------------------------------------------  ------- 
 An acquisition or disposal of instruments with similar economic 
  effect to qualifying financial instruments 
-------------------------------------------------------------------------------------------------------------------------  ------- 
 An event changing the breakdown of voting rights 
-------------------------------------------------------------------------------------------------------------------------  ------- 
 Other (please 
  specify): 
-----------------------------  ------------------------------------------------------------------------------------------  ------- 
 3. Full name of person(s) subject                                                                               LSP Advisory B.V. 
  to the                                                                                               LSP Life Sciences Fund N.V. 
  notification obligation: (iii) 
---------------------------------------------------------------------  ----------------------------------------------------------- 
 4. Full name of shareholder(s)                                                                        LSP Life Sciences Fund N.V. 
  (if different from 3.):(iv) 
---------------------------------------------------------------------  ----------------------------------------------------------- 
 5. Date of the transaction and date                                                                                 22 March 2013 
  on 
  which the threshold is crossed 
  or 
  reached: (v) 
---------------------------------------------------------------------  ----------------------------------------------------------- 
 6. Date on which issuer notified:                                                                                   22 March 2013 
---------------------------------------------------------------------  ----------------------------------------------------------- 
 7. Threshold(s) that is/are crossed                                                                                      Below 3% 
  or 
  reached: (vi, vii) 
---------------------------------------------------------------------  ----------------------------------------------------------- 
 8. Notified details: 
---------------------------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
---------------------------------------------------------------------------------------------------------------------------------- 
 Class/type            Situation previous                      Resulting situation after the triggering 
  of                    to the triggering                       transaction 
  shares                transaction 
 
  if possible 
  using 
  the ISIN CODE 
--------------------  --------------------------------------  -------------------------------------------------------------------- 
                       Number              Number              Number            Number of voting         % of voting rights 
                        of                  of                  of shares         rights                   (x) 
                        Shares              Voting 
                                            Rights 
--------------------  ------------------  ------------------  ----------------  -----------------------  ------------------------- 
                                                               Direct            Direct        Indirect   Direct       Indirect 
                                                                                  (xi)          (xii) 
--------------------      ---      -----  -------  ----  ---  ----------------  ------------  ---------  -----------  ------------ 
 Lombard Medical 
  Technologies 
  plc                  0                   0%                  2,000,000         2,000,000                6.62 
                      ------------------  ------------------  ----------------  ------------  ---------  -----------  ------------ 
 (ISIN GB00B0Q5QP56) 
  20p ordinary 
   shares 
--------------------      ---      -----  -------  ----  ---  -------      ---  -------  ---  ---------      -------  ---  ------- 
 
 B: Qualifying Financial Instruments 
---------------------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------------------- 
 Type of financial                  Expiration      Exercise/                    Number of voting             % of voting 
  instrument                         date (xiii)     Conversion Period            rights that may              rights 
                                                     (xiv)                        be 
                                                                                  acquired if the 
                                                                                  instrument is 
                                                                                  exercised/ converted. 
---------------------------------  --------------  ---------------------------  ---------------------------  --------------------- 
 
 
 C: Financial Instruments with similar economic effect to Qualifying Financial 
  Instruments (xv, xvi) 
---------------------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------------------- 
 Type of financial         Exercise        Expiration     Exercise/              Number of voting             % of voting rights 
  instrument                price           date (xvii)    Conversion             rights instrument            (xix, xx) 
                                                           period                 refers to 
                                                           (xviii) 
------------------------  --------------  -------------  ---------------------  ---------------------------  --------------------- 
                                                                                                              Nominal       Delta 
------------------------  --------------  -------------  ---------------------  ---------------------------  ------------  ------- 
 
 
 Total (A+B+C) 
---------------------------------------------------------------------------------------------------------------------------------- 
 Number of voting rights                                                    Percentage of voting rights 
-------------------------------------------------------------------------  ------------------------------------------------------- 
 2,000,000                                                                  6.62 
-------------------------------------------------------------------------  ------------------------------------------------------- 
 9. Chain of controlled undertakings through which the voting rights and/or 
  the 
  financial instruments are effectively held, if applicable: (xxi) 
---------------------------------------------------------------------------------------------------------------------------------- 
 
                                                              LSP Life Sciences Fund N.V. holds 2,000,000 shares and is managed by 
                                                                                                                 LSP Advisory B.V. 
 
 Proxy Voting: 
---------------------------------------------------------------------------------------------------------------------------------- 
 10. Name of the proxy holder:                                                                                                 N/A 
---------------------------------------------------------------------------------------  ----------------------------------------- 
 11. Number of voting rights proxy holder will                                                                                 N/A 
  cease 
  to hold: 
---------------------------------------------------------------------------------------  ----------------------------------------- 
 12. Date on which proxy holder will cease to                                                                                  N/A 
  hold 
  voting rights: 
---------------------------------------------------------------------------------------  ----------------------------------------- 
 
 
  13. Additional information:                                                                                                  N/A 
-------------------------------------------------------------------------  ------------------------------------------------------- 
 14. Contact name:                                                                                                     Bas Vaessen 
-------------------------------------------------------------------------  ------------------------------------------------------- 
 15. Contact telephone number:                                                                                    + 31 20 6645 500 
-------------------------------------------------------------------------  ------------------------------------------------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLUVRAROKAOUAR

Lombard Medical Technologies (LSE:LMT)
Historical Stock Chart
From Jul 2024 to Jul 2024 Click Here for more Lombard Medical Technologies Charts.
Lombard Medical Technologies (LSE:LMT)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Lombard Medical Technologies Charts.